Table 1. Baseline social, demographic and clinical characteristics of patients on ART in an ambulatory HIV care program in western Kenya, by TB status.
Baseline Characteristics | TB/HIV co-infectedpatients on ART N = 5,186 | HIV-infected patientson ART N = 16,056 | Absolute or % Difference (95% CIof difference1) |
Age (years) | |||
Median (IQR) | 37.0 (31.4, 43.4) | 37.7 (31.6, 44.5) | 0.70 (0.414, 1.000) |
Male Gender | 2,406 (46.4%) | 5,600 (34.9%) | 0.115 (0.010, 0.131) |
N = 4,927 | N = 15,066 | ||
Employed Outside Home | 1,188 (24.1%) | 3,258 (21.6%) | 0.025 (0.011, 0.039) |
Post-Primary (>8 years) Education | N = 4,635 | N = 14,040 | |
2,035 (43.9%) | 5,677 (40.4%) | 0.035 (0.018, 0.051) | |
Clinic Location | |||
Urban | 2,724 (52.5%) | 7,676 (47.8%) | 0.047 (0.032, 0.063) |
CD4 count (cells/ml) at ART start | N = 3,586 | N = 12,673 | |
Median (IQR) | 77 (29, 146) | 109 (47, 175) | 32.5 (25.85, 33.51) |
CD4 count (cells/ml) at ART start | N = 3,586 | N = 12,673 | |
0–49 | 1,330 (37.1%) | 3,292 (26.0%) | 0.111 (0.081, 0.141)2 |
50–199 | 1,810 (50.5%) | 7,284 (57.5%) | −0.070 (−0.096, −0.044) |
≥200 | 446 (12.4%) | 2,097 (16.6%) | −0.041 (−0.076, −0.007) |
Weight (Kg) at ART start | N = 5,285 | N = 15,867 | |
Median (IQR) | 52.5 (46, 59) | 55 (48.5, 62) | 2.5 (2.374, 3.031) |
BMI | N = 4,579 | N = 14,241 | |
Median (IQR) | 18.7 (16.9, 20.7) | 19.8 (17.8, 22.1) | 1.1 (1.123, 1.341) |
ADE3 (overall) | 736 (14.2%) | 1,317 (8.2%) | |
CD4 (cells/ml) at ART start | N = 3,586 | N = 12,673 | 0.06 (0.049, 0.070) |
0–49 | 244 (18.4%) | 415 (12.6%) | 1.275 (1.027, 1.581) |
50–199 | 237 (13.1%) | 439 (6.1%) | 1.100 (0.886, 1.364) |
≥200 | 55 (12.3%) | 194 (9.3%) | 0.503 (0.359, 0.698) |
Perfect Adherence to ART | N = 4,838 | N = 14,777 | |
3,852 (79.6%) | 11,590 (78.4%) | 0.012 (−0.001, 0.025) |
Difference between proportions (categorical variables) or means (continuous variables) of TB versus non-TB group.
Difference in the proportion of subjects with CD4<50 cells/ml in the TB versus the non-TB group.
Patients presenting with an AIDS-defining event (other than extra-pulmonary TB) 3 months prior and 2 months after ART initiation (some CD4 data are missing).